We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$171B
1-Year Est. Return
24.68%
This Fund
S&P 500
This Quarter
Est. Return
-0.2%
1 Year Est. Return
+24.68%
3 Year Est. Return
+62.17%
5 Year Est. Return
+55.89%
10 Year Est. Return
+171.9%
AUM
$147B
AUM Growth
+$7.72B
(+5.5%)
Cap. Flow
+$9.48B
Cap. Flow
% of AUM
6.43%
Top 10 Holdings %
Top 10 Hldgs %
41.95%
Holding
4,221
New
328
Increased
2,776
Reduced
891
Closed
131
Avg Time Held Equity + Options
16.9
quarters
Top 10 Avg Time Held Equity + Options
5.9
quarters
Top 20 Avg Time Held Equity + Options
16.1
quarters
Avg Time Held Equity only
16.9
quarters
Top 10 Avg Time Held Equity only
5.9
quarters
Top 20 Avg Time Held Equity only
16.1
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$888M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$700M |
| 3 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$408M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$338M |
| 5 |
Vanguard Russell 1000 Value ETF
VONV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$248M |
| 2 |
Schwab US Large- Cap ETF
SCHX
|
+$41.4M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$39.9M |
| 4 |
Schwab US Large-Cap Value ETF
SCHV
|
+$34.6M |
| 5 |
Schwab US Mid-Cap ETF
SCHM
|
+$32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 75.77% |
| 2 | Technology | 8.02% |
| 3 | Financials | 3.7% |
| 4 | Industrials | 2.22% |
| 5 | Healthcare | 2.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3951
American Battery Technology Co
ABAT
$267M
| $73.6K | ﹤0.01% |
26,385
+7,121
| +37% | +$27.5K |
2025 Q1
4 quarters
|
|
3952
Eve Holding
EVEX
$558M
| $73.3K | ﹤0.01% |
29,553
+12,517
| +73% | +$42.7K |
2025 Q3
2 quarters
|
|
3953
Saba Capital Income & Opportunities Fund
BRW
$299M
| $72.8K | ﹤0.01% |
+10,807
| New | +$72K |
2026 Q1
0 quarters
|
|
3954
Genius Sports
GENI
$1.74B
| $72.8K | ﹤0.01% |
+16,431
| New | +$117K |
2026 Q1
0 quarters
|
|
3955
Rezolve AI
RZLV
$725M
| $71.9K | ﹤0.01% |
+28,105
| New | +$79.3K |
2026 Q1
0 quarters
|
|
3956
Cardiff Oncology
CRDF
$82.5M
| $70.6K | ﹤0.01% |
43,610
+6,156
| +16% | +$12.6K |
2022 Q3
14 quarters
|
|
3957
Verastem
VSTM
$753M
| $70.6K | ﹤0.01% |
13,324
-1,697
| -11% | -$10.5K |
2025 Q4
1 quarter
|
|
3958
Aveanna Healthcare
AVAH
$2.67B
| $70.1K | ﹤0.01% |
10,885
-5,592
| -34% | -$43.2K |
2022 Q4
13 quarters
|
|
3959
Amplify Energy
AMPY
$187M
| $69.8K | ﹤0.01% |
11,185
+257
| +2% | +$1.4K |
2025 Q1
4 quarters
|
|
3960
Ur-Energy
URG
$381M
| $68.9K | ﹤0.01% |
46,263
-2,066
| -4% | -$3.37K |
2025 Q2
3 quarters
|
|
3961
Solid Power
SLDP
$523M
| $65.4K | ﹤0.01% |
21,813
+1,160
| +6% | +$4.67K |
2025 Q2
3 quarters
|
|
3962
BlackRock Enhanced International Dividend Trust
BGY
$514M
| $64.7K | ﹤0.01% |
11,953
-428
| -3% | -$2.51K |
2025 Q4
1 quarter
|
|
3963
American Resources Corp
AREC
$166M
| $64.6K | ﹤0.01% |
26,691
-4,000
| -13% | -$12.7K |
2024 Q4
5 quarters
|
|
3964
Humacyte
HUMA
$109M
| $63.8K | ﹤0.01% |
105,119
+49,204
| +88% | +$51.2K |
2025 Q3
2 quarters
|
|
|
IGR
3965
CBRE Global Real Estate Income Fund
IGR
$567M
| $63K | ﹤0.01% |
4,781
-1,465
| -23% | -$20.7K |
2025 Q3
2 quarters
|
|
3966
Eagle Point Credit Company
ECC
$412M
| $62K | ﹤0.01% |
16,485
+2,218
| +16% | +$10.3K |
2025 Q2
3 quarters
|
|
3967
AH Realty Trust
AHRT
$453M
| $61.5K | ﹤0.01% |
11,181
-27,912
| -71% | -$178K |
2025 Q2
3 quarters
|
|
3968
Richtech Robotics
RR
$351M
| $59.8K | ﹤0.01% |
28,618
+17,791
| +164% | +$54.7K |
2025 Q3
2 quarters
|
|
3969
Fate Therapeutics
FATE
$256M
| $59.3K | ﹤0.01% |
49,425
+25,534
| +107% | +$31.1K |
2025 Q3
2 quarters
|
|
3970
Optimum Communications Inc
OPTU
$359M
| $59.2K | ﹤0.01% |
45,564
+8,795
| +24% | +$13.8K |
2018 Q1
32 quarters
|
|
3971
PIMCO Strategic Income Fund
RCS
$239M
| $58.2K | ﹤0.01% |
10,854
-2,325
| -18% | -$13.4K |
2024 Q4
5 quarters
|
|
3972
X4 Pharmaceuticals
XFOR
$286M
| $57.1K | ﹤0.01% |
13,819
-2,608
| -16% | -$9.77K |
2025 Q4
1 quarter
|
|
3973
Editas Medicine
EDIT
$432M
| $57K | ﹤0.01% |
+23,084
| New | +$48.9K |
2026 Q1
0 quarters
|
|
3974
TuHURA Biosciences
HURA
$125M
| $55.3K | ﹤0.01% |
+30,894
| New | +$37.9K |
2026 Q1
0 quarters
|
|
3975
Expensify
EXFY
$222M
| $54.9K | ﹤0.01% |
+63,059
| New | +$74.8K |
2026 Q1
0 quarters
|
|
Similar funds
Creative Planning's Q1 2026 Portfolio in Review
As of Q1 2026, Creative Planning held 4,221 positions worth $147B, up 5.5% from $140B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Creative Planning deployed $9.48B of net new capital in Q1 2026, opening 328 new positions and adding to 2,776 existing holdings. Its largest new stake was Innovator US Equity Power Buffer ETF August: 270,134 shares worth $11.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 76% of assets, down from 76% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $248M trimmed.
- Creative Planning's largest Q1 2026 buy was Innovator US Equity Power Buffer ETF August: 270,134 shares worth $11.5M.
- Creative Planning added most to Vanguard Short-Term Bond ETF in Q1 2026, an estimated $888M increase.
- Creative Planning's biggest Q1 2026 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $248M.
- Creative Planning fully exited CyberArk in Q1 2026, selling an estimated $9.29M.
- Creative Planning's ten largest holdings make up 42% of its $147B portfolio in Q1 2026.
- Creative Planning opened 328 new positions and closed 131 in Q1 2026.
- Creative Planning's portfolio value rose 5.5% quarter-over-quarter to $147B.
Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.